These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis. Bachert C Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Van Cauwenberge P; Juniper EF Clin Exp Allergy; 2000 Jun; 30(6):891-9. PubMed ID: 10848909 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. LaForce CF; Corren J; Wheeler WJ; Berger WE; Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675 [TBL] [Abstract][Full Text] [Related]
5. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734 [TBL] [Abstract][Full Text] [Related]
6. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis. Wahn U; Meltzer EO; Finn AF; Kowalski ML; Decosta P; Hedlin G; Scheinmann P; Bachert C; Rosado Pinto JE; Baena-Cagnani C; Potter P; Simons FE; Ruuth E J Allergy Clin Immunol; 2003 Apr; 111(4):763-9. PubMed ID: 12704355 [TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis. Lee DK; Gray RD; Robb FM; Fujihara S; Lipworth BJ Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines. Bensch GW; Nelson HS; Borish LC Ann Allergy Asthma Immunol; 2002 May; 88(5):457-62. PubMed ID: 12027065 [TBL] [Abstract][Full Text] [Related]
9. Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; a randomized, double-blind, active-controlled trial. Finn AF; Aaronson D; Korenblat P; Lumry W; Settipane G; Spector S; Woehler T; Drda K; Wood CC Am J Rhinol; 1998; 12(6):441-9. PubMed ID: 9883302 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies. Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959 [TBL] [Abstract][Full Text] [Related]
11. A non-comparative trial of the efficacy and safety of fexofenadine for treatment of perennial allergic rhinitis. Bunnag C; Jareoncharsri P; Tunsuriyawong P; Pumhirun P; Limprasertsiri S; Chochaipanichnon L; Supiyaphun P; Kongpatanakul S Asian Pac J Allergy Immunol; 2000 Sep; 18(3):127-33. PubMed ID: 11270466 [TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis. Sussman GL; Mason J; Compton D; Stewart J; Ricard N J Allergy Clin Immunol; 1999 Jul; 104(1):100-6. PubMed ID: 10400846 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis. Casale TB; Andrade C; Qu R Allergy Asthma Proc; 1999; 20(3):193-8. PubMed ID: 10389553 [TBL] [Abstract][Full Text] [Related]
14. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Meltzer EO; Casale TB; Nathan RA; Thompson AK Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis]. López García A; Paz Martínez D; Orea Solano M; Hernández Valencia G; Ramírez García A; Ramírez Ojeda H; Sánchez Medal LF; Soda Mehry A; Velarde Domínguez T; Betancourt Suárez MA; Méndez Vera JL Rev Alerg Mex; 2001; 48(6):168-72. PubMed ID: 11802289 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis. Lee DK; Gardiner M; Haggart K; Fujihara S; Lipworth BJ Clin Exp Allergy; 2004 Apr; 34(4):650-3. PubMed ID: 15080821 [TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of 30 mg fexofenadine HCl bid in pediatric patients with allergic rhinitis. Ngamphaiboon J; Direkwattanachai C; Visitsunthorn N; Vangveeravong M; Tiensuwan M Asian Pac J Allergy Immunol; 2005 Dec; 23(4):169-74. PubMed ID: 16572735 [TBL] [Abstract][Full Text] [Related]
18. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis. Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564 [TBL] [Abstract][Full Text] [Related]
19. H1-antihistaminic activity of cetirizine and fexofenadine in allergic children. Simons FE; J Semus M; Goritz SS; Simons KJ Pediatr Allergy Immunol; 2003 Jun; 14(3):207-11. PubMed ID: 12787300 [TBL] [Abstract][Full Text] [Related]
20. Assessment of the antiobstructive effect of fexofenadine on nasal allergy challenge in patients with seasonal allergic rhinitis. Mösges R; Lehmacher W; Pasch N; Vent J Asian Pac J Allergy Immunol; 2009 Dec; 27(4):181-90. PubMed ID: 20232572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]